share_log

NLS Pharmaceutics将于2024年9月27日除权除息,40股合为1股

NLS Pharmaceutics To Carry Out 1-for-40 Reverse Stock Split On September 27th, 2024

Futu News ·  Sep 26 07:35

September 25th (Eastern Time) - $NLS Pharmaceutics (NLSP.US)$ is about to implement a 1-for-40 reverse stock split of shares. The shares will begin trading on a split-adjusted basis from September 27th, 2024.

$NLS Pharmaceutics (NLSP.US)$ rose 2.51% and closed at $0.139 on September 24th with a turnover of $27,097. $NLS Pharmaceutics (NLSP.US)$ now has a total market capitalization of $6.51 million.


What Is a Reverse Stock Split?

A reverse stock split consolidates the number of existing shares of stock held by shareholders into fewer shares. It does not directly impact a company's value. And it can signal a company in distress since it raises the value of otherwise low-priced shares.

Note:

The company's actual implementation is subject to the final disclosure submitted to the exchange. The information provided herein is for reference only.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment